Alpha Tau Medical Ltd-cl A (DRTS) Technical Analysis
$5.00▲3.95%
Market is closed - opens 8 PM, 19 Dec 2025
Insights
- Alpha Tau Medical-cl A is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Alpha Tau Medical-cl A stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Alpha Tau Medical-cl A stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Alpha Tau Medical-cl A stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 61.38 | Sell |
Stochastic | 74.2, 89.0 | Neutral |
Ultimate Oscillator | 62.59 | Neutral |
Stochastic Relative Strength Index | 83.69, 91.16 | Sell |
Moving Average Convergence Divergence | 0.3, 0.18 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.62 | Buy |
20 | 4.2 | Buy |
50 | 4.06 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.69 | Buy |
20 | 4.4 | Buy |
50 | 4.12 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.55 | Buy |
20 | 4.46 | Buy |
50 | 4.33 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 5.05 | Buy |
20 | 4.76 | Buy |
50 | 4.42 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 5.15 | Buy |
20 | 5.01 | Buy |
50 | 4.51 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 5.59 |
Resistance L2 | 5.39 |
Resistance L1 | 5.26 |
Pivot Point | 5.06 |
Support L1 | 4.93 |
Support L2 | 4.73 |
Support L3 | 4.6 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.